article thumbnail

Compounded semaglutide side effects

The Checkup by Singlecare

Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. Is compounded semaglutide safe?

article thumbnail

FDA: Updated Guidance to Increase Ibuprofen Supply for Children

Drug Topics

The FDA has updated its compounding guidelines for licensed pharmacies, hospitals, and health systems.

FDA 247
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paediatric oral compounding: expert insights from a global study

Hospital Pharmacy Europe

A new global study from the International Pharmaceutical Federation (FIP)s Pediatric Formulations Focus Group is the first to report current and global paediatric oral extemporaneous compounding practices. The FIP study aimed to identify current global paediatric oral extemporaneous compounding practices, challenges and needs.

article thumbnail

STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls

STAT

One of the largest compound pharmacy operations in the U.S. recently recalled a slew of injectable medicines used by hospitals over concerns about possible side effects and a newly released regulatory report underscores the extent of the problem. facility run by Central Admixture Pharmacy Services.

article thumbnail

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

Pharmacy Times

Off-label semaglutide has been linked to serious adverse effects, calling for increased regulation around compounding.

article thumbnail

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

In the early days of the Covid pandemic, gravely ill patients began to fill America’s hospitals. In a 2021 APC survey, more than 80 pharmacies nationwide reported they had provided compounded versions of those essential drugs to hospitals under the temporary guidance.

article thumbnail

STAT+: Pharmalittle: We’re watching a ban compounded versions of GLP-1s, a Biogen acquisition, and more

STAT

Australia to ban compounded versions of blockbuster drugs Ozempic and Mounjaro, Reuters reports. But the country’s health minister, Mark Butler, says that it’s harder to ensure the safety of compounded drugs, noting that one Australian was hospitalized after taking a compounded GLP-1 product.